1. Home
  2. EXPO vs ADMA Comparison

EXPO vs ADMA Comparison

Compare EXPO & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXPO
  • ADMA
  • Stock Information
  • Founded
  • EXPO 1967
  • ADMA 2004
  • Country
  • EXPO United States
  • ADMA United States
  • Employees
  • EXPO N/A
  • ADMA N/A
  • Industry
  • EXPO Professional Services
  • ADMA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • EXPO Consumer Discretionary
  • ADMA Health Care
  • Exchange
  • EXPO Nasdaq
  • ADMA Nasdaq
  • Market Cap
  • EXPO 3.5B
  • ADMA 3.7B
  • IPO Year
  • EXPO 1990
  • ADMA N/A
  • Fundamental
  • Price
  • EXPO $67.76
  • ADMA $14.13
  • Analyst Decision
  • EXPO
  • ADMA Strong Buy
  • Analyst Count
  • EXPO 0
  • ADMA 3
  • Target Price
  • EXPO N/A
  • ADMA $27.67
  • AVG Volume (30 Days)
  • EXPO 458.4K
  • ADMA 3.3M
  • Earning Date
  • EXPO 10-23-2025
  • ADMA 11-06-2025
  • Dividend Yield
  • EXPO 1.79%
  • ADMA N/A
  • EPS Growth
  • EXPO N/A
  • ADMA 469.09
  • EPS
  • EXPO 1.99
  • ADMA 0.85
  • Revenue
  • EXPO $519,154,000.00
  • ADMA $474,174,000.00
  • Revenue This Year
  • EXPO $4.31
  • ADMA $21.08
  • Revenue Next Year
  • EXPO $7.48
  • ADMA $25.98
  • P/E Ratio
  • EXPO $33.71
  • ADMA $17.35
  • Revenue Growth
  • EXPO 2.10
  • ADMA 43.58
  • 52 Week Low
  • EXPO $63.81
  • ADMA $13.50
  • 52 Week High
  • EXPO $115.75
  • ADMA $25.67
  • Technical
  • Relative Strength Index (RSI)
  • EXPO 40.45
  • ADMA 31.93
  • Support Level
  • EXPO $68.68
  • ADMA $14.43
  • Resistance Level
  • EXPO $69.92
  • ADMA $15.38
  • Average True Range (ATR)
  • EXPO 1.33
  • ADMA 0.53
  • MACD
  • EXPO -0.15
  • ADMA -0.09
  • Stochastic Oscillator
  • EXPO 27.35
  • ADMA 3.83

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Share on Social Networks: